BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/05/2007

FDA Announces Enforcement Action Against Unapproved Guaifenesin-Containing Timed-Release Drugs

The FDA is taking enforcement action against hundreds of unapproved timed-release drug products containing guaifenesin, which are marketed to relieve symptoms of cough, cold, and similar conditions, and against individuals who manufacture or ship these products without approval.

Source: Federal Register — Food and Drug AdministrationOpen original release →